Stifel on Altria (MO): 'NJOY Aces Menthol Application – FDA Authorizes the First Menthol E-vapor'
Tweet Send to a Friend
Stifel analyst Matthew Smith reiterated a Buy rating and $50.00 price target on Altria (NYSE: MO)The analyst comments "FDA announced ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
